Martin Hoffmann

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

Michael Pfreundschuh, Jöerg Schubert, Marita Ziepert et al. · The Lancet Oncology · 2008 · 1.1K citations

Medicine, Immunology, Oncology +7

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Clinical outcomes of locked plating of distal femoral fractures in a retrospective cohort

Martin Hoffmann, Clifford B. Jones, Debra L. Sietsema et al. · Journal of Orthopaedic Surgery and Research · 2013 · 175 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +15

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Outcome of periprosthetic distal femoral fractures following knee arthroplasty

Martin Hoffmann, Clifford B. Jones, Debra L. Sietsema et al. · Injury · 2012 · 156 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14